Centessa Pharmaceuticals plc (CNTA) Enterprise Value
Price: $13.61
Market Cap: $1.81B
Avg Volume: 1.04M
Market Cap: $1.81B
Avg Volume: 1.04M
Country: GB
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Enterprise Value Summary (Quarterly)
According to Centessa Pharmaceuticals plc's latest quarterly financial reports:
- The enterprise value (EV) is 1.95B, which includes the market capitalization, debt, and subtracts cash and cash equivalents. EV provides a more comprehensive measure of a company's total value.
- The market capitalization is 1.92B, which is calculated by multiplying the current share price by the total number of outstanding shares.
- The stock price is $16.75, with 132.05M shares outstanding.
- The company has 383.22M in cash and cash equivalents and 117.23M in total debt.
Enterprise Value (EV) Formula:
EV = Market Cap + Total Debt - Cash and Cash Equivalents
Enterprise value is often used instead of market cap because it provides a more accurate valuation of a company by including debt and subtracting cash, giving a fuller picture of the company's total value.
Enterprise Value
$1.95B
Market Cap
$2.21B
Total Debt
$117.23M
Cash and Equivalents
$383.22M
Historical Enterprise Value
Centessa Pharmaceuticals plc Historical Enterprise Values
The table below shows various enterprise value metrics for each quarter, with the latest data available for 2024-12-31.
| Date | Enterprise Value | EV Change (%) | Stock Price | Number of Shares | Market Cap | Cash & Equivalents | Total Debt |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | $1.95B | 25.65% | $16.75 | 132.05M | $2.21B | $383.22M | $117.23M |
| September 30, 2024 | $1.55B | 68.00% | $15.99 | 116.25M | $1.86B | $395.03M | $84.72M |
| June 30, 2024 | $921.78M | -14.22% | $8.8 | 109.49M | $963.50M | $127.37M | $85.65M |
| March 31, 2024 | $1.07B | 46.00% | $11.08 | 99.89M | $1.11B | $118.22M | $86.07M |
| December 31, 2023 | $736.03M | 36.98% | $7.96 | 97.92M | $779.47M | $128.03M | $84.59M |
| September 30, 2023 | $537.32M | 2.01% | $6.47 | 96.65M | $625.31M | $171.50M | $83.50M |
| June 30, 2023 | $526.75M | 181.93% | $6.19 | 95.16M | $589.06M | $145.22M | $82.91M |
| March 31, 2023 | $186.83M | -711.13% | $3.85 | 94.94M | $365.51M | $259.99M | $81.31M |
| December 31, 2022 | $-30.57M | -1296.46% | $3.1 | 94.60M | $293.27M | $393.64M | $69.80M |
| September 30, 2022 | $2.56M | -93.85% | $4.02 | 94.33M | $379.20M | $444.84M | $68.20M |
| June 30, 2022 | $41.55M | -87.86% | $4.87 | 94.11M | $458.31M | $484.16M | $67.40M |
| March 31, 2022 | $342.17M | -30.64% | $8.97 | 90.51M | $811.83M | $544.47M | $74.80M |
| December 31, 2021 | $493.30M | -46.53% | $11.26 | 89.94M | $1.01B | $595.08M | $75.70M |
| September 30, 2021 | $922.51M | 15.76% | $16.7 | 89.90M | $1.50B | $578.82M | $- |
| June 30, 2021 | $796.95M | -50.29% | $22.21 | 63.52M | $1.41B | $613.76M | $- |
| March 31, 2021 | $1.60B | 393.81% | $21.75 | 87.42M | $1.90B | $298.61M | $291.00K |
| December 31, 2020 | $324.65M | -89.49% | $21.75 | 15.00M | $326.25M | $7.23M | $5.63M |
| September 30, 2020 | $3.09B | - | $21.75 | 142.06M | $3.09B | $- | $- |
| June 30, 2020 | $- | - | $21.75 | - | $- | $- | $- |
| March 31, 2020 | $1.54B | - | $21.75 | 70.89M | $1.54B | $- | $- |
Related Metrics
Explore detailed financial metrics and analysis for CNTA.